Monashee Investment Management’s Akero Therapeutics AKRO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-65,000	Closed	-$2.21M	–	42
2022 Q3	$2.21M	Buy	+65,000	New	+$2.21M	0.82%	20
2019 Q3	–	Sell	-110,000	Closed	-$2.11M	–	116
2019 Q2	$2.11M	Buy	+110,000	New	+$2.11M	0.55%	53